Front Row Advisors LLC Ark Genomic Revolution ETF (De Transaction History
Front Row Advisors LLC
- $250 Million
- Q1 2025
A detailed history of Front Row Advisors LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Front Row Advisors LLC holds 5 shares of ARKG stock, worth $110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$110
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARKG
# of Institutions
277Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$75.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$72.8 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$56.6 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$52.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$26.7 Million0.0% of portfolio